ExonHit to pay $12.5M in cash and $10M in stock for RedPath Integrated Pathology acquisition

ExonHit Therapeutics (Paris:ALEHT):

• Acquisition paid for in cash and by issuance of shares
• Issuance of 2,834,412 new ExonHit shares

The extraordinary shareholders' meeting of convened to approve the acquisition of the US company, RedPath Integrated Pathology, will be held on first notice, on Monday, June 28, 2010 at 17:30 CET, at the Company's headquarters, 63-65 boulevard Masséna, 75013 Paris, France. If the quorum is not met, the meeting will be held, on second notice, on July 8, 2010, at 16:00 CET, at the Company's headquarters.

The notice of the meeting including the final terms of the transaction was published today, June 9, 2010 in the legal gazette (Bulletin des Annnonces Légales et Obligatoires or BALO). It includes the agenda of the meeting, the resolutions submitted to shareholders' vote and the main conditions for attending the meeting and voting.

According to the terms of the agreement, upon approval of the transaction, ExonHit will pay upfront USD 12.5 million in cash and USD 10 million in stock at the closing of the transaction. On the basis of the euro/dollar conversion rate and of the ExonHit share price over the reference period described in the contribution agreement (i.e. May 3, 2010 - June 7, 2010) 2,834,412 new ExonHit shares will be issued, representing 7.95% of the 35,656,294 ordinary shares that will be outstanding after the closing.

All documents and information about the meeting are available to shareholders in accordance with current French regulations. In particular, the reports from the Management Board and from the appraisers (available in French only), as well as voting and proxy forms, may be found on the Company's website: http://www.exonhit.com (section "Investors"/"general meeting").

All shareholders are invited to participate, either by attending the shareholders' meeting and voting in person, or by mailing their vote, or by proxy. Such documents must be received by the Company no later than Friday, June 25, 2010. The participation of each shareholder to this meeting is important.